1. Home
  2. ASTC vs RGNT Comparison

ASTC vs RGNT Comparison

Compare ASTC & RGNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Astrotech Corporation (DE)

ASTC

Astrotech Corporation (DE)

HOLD

Current Price

$7.20

Market Cap

14.5M

Sector

Industrials

ML Signal

HOLD

Logo Regentis Biomaterials Ltd. Ordinary Shares

RGNT

Regentis Biomaterials Ltd. Ordinary Shares

N/A

Current Price

$1.96

Market Cap

14.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ASTC
RGNT
Founded
1984
2004
Country
United States
Israel
Employees
32
8
Industry
Biotechnology: Laboratory Analytical Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
14.5M
14.3M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
ASTC
RGNT
Price
$7.20
$1.96
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
226.0K
164.1K
Earning Date
05-12-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
2600.00
N/A
EPS
0.25
N/A
Revenue
$1,000,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$30.24
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.92
$1.23
52 Week High
$68.85
$15.50

Technical Indicators

Market Signals
Indicator
ASTC
RGNT
Relative Strength Index (RSI) 38.68 39.20
Support Level $3.40 $1.82
Resistance Level $14.89 $3.35
Average True Range (ATR) 0.82 0.37
MACD 0.08 -0.18
Stochastic Oscillator 13.82 11.84

Price Performance

Historical Comparison
ASTC
RGNT

About ASTC Astrotech Corporation (DE)

Astrotech Corp is a science and technology development company. The firm invents, acquires, and commercializes technological innovations sourced from internal research, universities, laboratories, and research institutions. The 1st Detect develops, manufactures, and sells chemical analyzers for use in the airport security, military, and breath analysis markets. AgLAB develops a series of mass spectrometers for use in the agriculture market.

About RGNT Regentis Biomaterials Ltd. Ordinary Shares

Regentis Biomaterials Ltd is a regenerative medicine company dedicated to developing tissue repair solutions that restore health and enhance the quality of life of patients. It is focused on orthopedic treatments using its Gelrin platform based on degradable hydrogel implants to regenerate damaged or diseased tissue (inflamed cartilage and bone tissue). Gelrin is a hydrogel matrix of polyethylene glycol diacrylate and denatured fibrinogen (a biologically inactivated protein that normally has a role in blood clotting). Its product is GelrinC, a cell-free, off-the-shelf hydrogel that is cured into an implant in the knee for the treatment of painful injuries to articular knee cartilage.

Share on Social Networks: